Markets:

Overview

News

Currencies

International

Treasuries

Cytodyn Inc (OP:CYDY)

0.2235 -0.0075 (-3.25%)

Streaming Delayed Price Updated: 11:24 AM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cytodyn Inc

A Penny Stock To Watch In Challenging Cancer Space ↗

May 28, 2025

The author has a $2.75 Price Target on CytoDyn (CYDY) in the Next 6 to 12 months, representing significant upside from its current price of around $0.32.

Via Benzinga

When Penny Stocks Can Become Compelling: A Long-Term Buy With CYDY ↗

April 03, 2025

CytoDyn represents a speculative bet on a once-celebrated drug that is now steadily rebuilding its case. If leronlimab can fulfill its early promise in metastatic triple-negative breast cancer, the...

Via Talk Markets

Topics Stocks / Equities

FDA Advisory Committee Shakeup and Implications for Capricor Therapeutics ↗

April 01, 2025

Don't be scared off up by the recent Trump FDA overhaul. The changes are very positive for Capricor Therapeutics moving forward (2025–2028).

Via Talk Markets

Topics Government Stocks / Equities

Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December ↗

January 17, 2023

On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate...

Via Benzinga

OTC Market Group's Most Active List In November: A Dive Into The Names Experiencing Volume Changes ↗

December 13, 2022

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022.

Via Benzinga

Most Active On The OTC Markets In September – A Look Back As October Comes To A Close ↗

October 27, 2022

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) declined by 9.62% in September – its largest decline in 2022.

Via Benzinga

OTC Markets' Most Active Securities Sees A Shake-up In July ↗

August 16, 2022

July gave world markets a breather from 2022’s poor financial conditions.

Via Benzinga

These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month ↗

August 05, 2022

The month of July saw $37.3 billion in trading volume for stocks that trade on the OTCQK and OTCQB. While some of the stocks that trade over-the-counter are considered penny stocks based on their share...

Via Benzinga

Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June ↗

July 18, 2022

Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June.

Via Benzinga

The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall ↗

March 31, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators ↗

February 14, 2022

Photo from Jason Briscoe on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant ↗

December 29, 2021

Pfizer (NYSE: PFE) is arguably one of the biggest leaders in COVID-19 technology, whether it’s their vaccine or their newly approved oral antiviral called Paxlovid. The...

Via Benzinga

These OTC Markets Securities had the Most Trading Activity in September ↗

October 12, 2021

Photo by Annie Spratt on Unsplash As the 3rd quarter came to a close in September, the OTC Markets saw a slight decrease in total trading volume even as companies reported...

Via Benzinga

OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities ↗

July 28, 2021

Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

What's Behind This Wild-Card Coronavirus Stock? ↗

June 08, 2021

Failure is not an option for this small-cap biotech developing a COVID-19 treatment.

Via The Motley Fool

CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines ↗

May 18, 2021

After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140...

Via Benzinga

CytoDyn Stock Falls After FDA Rebukes Claims On COVID-19 Treatment ↗

May 18, 2021

The FDA has accused CytoDyn Inc (OTC: CYDY) of trying to pick and choose data from two failed studies of leronlimab in COVID-19 patients to claim the drug is...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

These OTC Securities Had the Most Trading Activity in April ↗

May 12, 2021

April was another fascinating month in OTC Markets trading, as cryptocurrency, internatio...

Via Benzinga

Review Of Present Therapies For Covid-19 ↗

May 09, 2021

A summary of authorized drugs for Covid-19, those in development, and those that have failed.

Via Talk Markets

Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today ↗

April 08, 2021

Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday....

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.